Adverum Biotechnologies (NASDAQ:ADVM) & Lexeo Therapeutics (NASDAQ:LXEO) Head-To-Head Analysis
Adverum Biotechnologies (NASDAQ:ADVM – Get Free Report) and Lexeo Therapeutics (NASDAQ:LXEO – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends. Valuation & Earnings This table compares Adverum […]
More Stories
BP (NYSE:BP) Upgraded at StockNews.com
StockNews.com upgraded shares of BP (NYSE:BP – Free Report) from a hold rating to a buy rating in a report...
BMO Capital Markets Raises Antero Resources (NYSE:AR) Price Target to $34.00
Antero Resources (NYSE:AR – Free Report) had its price target increased by BMO Capital Markets from $33.00 to $34.00 in...
Boeing (NYSE:BA) Price Target Cut to $195.00
Boeing (NYSE:BA – Free Report) had its target price cut by Deutsche Bank Aktiengesellschaft from $225.00 to $195.00 in a...
AMN Healthcare Services (NYSE:AMN) Earns “Market Outperform” Rating from JMP Securities
JMP Securities restated their market outperform rating on shares of AMN Healthcare Services (NYSE:AMN – Free Report) in a report...
Albany International (NYSE:AIN) PT Lowered to $81.00 at TD Cowen
Albany International (NYSE:AIN – Free Report) had its target price reduced by TD Cowen from $95.00 to $81.00 in a...
Truist Financial Boosts AECOM (NYSE:ACM) Price Target to $119.00
AECOM (NYSE:ACM – Free Report) had its price target lifted by Truist Financial from $108.00 to $119.00 in a research...